|
|
Volumn 13, Issue 3, 2002, Pages 392-398
|
|
Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer
a
|
|
Author keywords
Ovarian cancer; Oxaliplatin; Phase I; Topotecan
|
|
Indexed keywords
7 ETHYL 10 HYDROXYCAMPTOTHECIN;
CAMPTOTHECIN DERIVATIVE;
CISPLATIN DERIVATIVE;
DNA TOPOISOMERASE;
DNA TOPOISOMERASE INHIBITOR;
GRANULOCYTE COLONY STIMULATING FACTOR;
LOPERAMIDE;
OXALIPLATIN;
PACLITAXEL;
PLATINUM DERIVATIVE;
TOPOTECAN;
ANTINEOPLASTIC AGENT;
PLATINUM COMPLEX;
ADULT;
AGED;
ANEMIA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER INHIBITION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLON CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOSE RESPONSE;
DRUG EFFECT;
DRUG POTENTIATION;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
HUMAN CELL;
MALE;
MAXIMUM TOLERATED DOSE;
MOUSE;
MUCOSA INFLAMMATION;
NEUTROPENIA;
NONHUMAN;
OVARY CANCER;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTOPENIA;
TUMOR XENOGRAFT;
VOMITING;
ANIMAL;
BAGG ALBINO MOUSE;
CELL CULTURE;
CELL CYCLE;
COLORECTAL TUMOR;
COMPARATIVE STUDY;
DRUG SCREENING;
EVALUATION;
MIDDLE AGED;
OVARY TUMOR;
ADULT;
AGED;
ANIMAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
CELL CYCLE;
COLORECTAL NEOPLASMS;
COMPARATIVE STUDY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG EVALUATION, PRECLINICAL;
FEMALE;
HUMAN;
MALE;
MAXIMUM TOLERATED DOSE;
MICE;
MICE, INBRED BALB C;
MIDDLE AGE;
ORGANOPLATINUM COMPOUNDS;
OVARIAN NEOPLASMS;
SUPPORT, NON-U.S. GOV'T;
TOPOTECAN;
TUMOR CELLS, CULTURED;
ANIMALS;
HUMANS;
MIDDLE AGED;
|
|
EID: 0036018899
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdf030 Document Type: Article |
|
Times cited : (9)
|
|
References (16)
|
